A new publication referencing elamipretide appeared on October 19, 2026. The paper, titled "Report from the 2026 Barth Syndrome Foundation International Scientific, Medical & Family Conference: Advances in Barth Syndrome Research, Therapy Development, and Clinical Care," was published in the Journal of Developmental Biology.
The publication documents proceedings from the Barth Syndrome Foundation's international conference, which covers scientific, medical, and family perspectives on the condition. Elamipretide is approved and discussed in the context of this conference report.
No specific findings, outcomes, or data points from the publication were provided beyond its title, journal, and publication date. The report is identified by PubMed ID 42924728 and is available through the National Library of Medicine's PubMed database.
This entry reflects only the existence and bibliographic details of the publication as recorded. Readers interested in elamipretide can consult the compound overview for additional context on its approved status and background.